U.S. Food and Drug Administration approved Alnylam's drug to treat a rare and deadly heart disease on Thursday, allowing the ...
August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...
Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that it has entered into a sixth ...
If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.
A federal judge has blocked the cuts while lawsuits move through the courts but it has caused uncertainty and anxiety among ...
The Tryvio REMS program was established due to the risk of birth defects associated with the ERA drug class. Prior to dispensing Tryvio, patients of reproductive potential were required to report a ...
The FDA is reinstating fired probationary workers after a federal judge ruled their terminations were unlawful and must be ...
The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...
Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...
The Oklahoma Highway Patrol issued a Blue Alert on March 16, 2025, for Billy Wayne Williams, a suspect wanted in connection ...
Despite a federal judge ordering deportation flights of Venezuelans to cease, video shows more deportees arriving in El ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback